HEADER HYDROLASE/HYDROLASE INHIBITOR 07-DEC-14 4X69 TITLE CRYSTAL STRUCTURE OF OP0595 COMPLEXED WITH CTX-M-44 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE TOHO-1; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: BLA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.YAMADA,T.WATANABE REVDAT 6 23-OCT-24 4X69 1 REMARK REVDAT 5 08-NOV-23 4X69 1 REMARK REVDAT 4 05-FEB-20 4X69 1 REMARK REVDAT 3 14-OCT-15 4X69 1 JRNL REVDAT 2 15-JUL-15 4X69 1 REMARK REVDAT 1 01-JUL-15 4X69 0 JRNL AUTH A.MORINAKA,Y.TSUTSUMI,M.YAMADA,K.SUZUKI,T.WATANABE,T.ABE, JRNL AUTH 2 T.FURUUCHI,S.INAMURA,Y.SAKAMAKI,N.MITSUHASHI,T.IDA, JRNL AUTH 3 D.M.LIVERMORE JRNL TITL OP0595, A NEW DIAZABICYCLOOCTANE: MODE OF ACTION AS A SERINE JRNL TITL 2 BETA-LACTAMASE INHIBITOR, ANTIBIOTIC AND BETA-LACTAM JRNL TITL 3 'ENHANCER' JRNL REF J.ANTIMICROB.CHEMOTHER. V. 70 2779 2015 JRNL REFN ESSN 1460-2091 JRNL PMID 26089439 JRNL DOI 10.1093/JAC/DKV166 REMARK 2 REMARK 2 RESOLUTION. 1.42 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC_5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.42 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 77420 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4113 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3952 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 368 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.25000 REMARK 3 B22 (A**2) : -0.37000 REMARK 3 B33 (A**2) : 0.69000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.10000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.072 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.072 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.042 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.049 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4X69 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1000205007. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 81658 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.420 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 24.1950 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.42 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.45500 REMARK 200 R SYM FOR SHELL (I) : 0.45500 REMARK 200 FOR SHELL : 2.173 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1IYS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, PH 8.0, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.49100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 26 REMARK 465 GLY B 26 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 227 CD CE NZ REMARK 470 LYS B 99 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -134.73 49.42 REMARK 500 VAL A 103 -132.60 -114.47 REMARK 500 SER A 220 -124.24 -104.67 REMARK 500 ASN B 54 18.96 56.93 REMARK 500 CYS B 69 -135.34 50.29 REMARK 500 VAL B 103 -131.87 -113.83 REMARK 500 ASN B 106 54.64 -140.20 REMARK 500 SER B 220 -127.23 -103.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OP0 A 301 REMARK 610 OP0 B 301 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OP0 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide OP0 B 301 and SER B REMARK 800 70 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4X68 RELATED DB: PDB DBREF 4X69 A 26 290 UNP Q47066 BLT1_ECOLX 30 291 DBREF 4X69 B 26 290 UNP Q47066 BLT1_ECOLX 30 291 SEQADV 4X69 GLY A 26 UNP Q47066 ALA 30 ENGINEERED MUTATION SEQADV 4X69 GLY B 26 UNP Q47066 ALA 30 ENGINEERED MUTATION SEQRES 1 A 262 GLY ASN SER VAL GLN GLN GLN LEU GLU ALA LEU GLU LYS SEQRES 2 A 262 SER SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN THR SEQRES 3 A 262 ALA ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU ARG SEQRES 4 A 262 PHE ALA MET CYS SER THR SER LYS VAL MET ALA ALA ALA SEQRES 5 A 262 ALA VAL LEU LYS GLN SER GLU SER ASP LYS HIS LEU LEU SEQRES 6 A 262 ASN GLN ARG VAL GLU ILE LYS LYS SER ASP LEU VAL ASN SEQRES 7 A 262 TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR MET SEQRES 8 A 262 THR LEU ALA GLU LEU GLY ALA ALA ALA LEU GLN TYR SER SEQRES 9 A 262 ASP ASN THR ALA MET ASN LYS LEU ILE ALA HIS LEU GLY SEQRES 10 A 262 GLY PRO ASP LYS VAL THR ALA PHE ALA ARG SER LEU GLY SEQRES 11 A 262 ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR LEU SEQRES 12 A 262 ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR THR SEQRES 13 A 262 PRO LEU ALA MET ALA GLN THR LEU LYS ASN LEU THR LEU SEQRES 14 A 262 GLY LYS ALA LEU ALA GLU THR GLN ARG ALA GLN LEU VAL SEQRES 15 A 262 THR TRP LEU LYS GLY ASN THR THR GLY SER ALA SER ILE SEQRES 16 A 262 ARG ALA GLY LEU PRO LYS SER TRP VAL VAL GLY ASP LYS SEQRES 17 A 262 THR GLY SER GLY ASP TYR GLY THR THR ASN ASP ILE ALA SEQRES 18 A 262 VAL ILE TRP PRO GLU ASN HIS ALA PRO LEU VAL LEU VAL SEQRES 19 A 262 THR TYR PHE THR GLN PRO GLU GLN LYS ALA GLU ARG ARG SEQRES 20 A 262 ARG ASP ILE LEU ALA ALA ALA ALA LYS ILE VAL THR HIS SEQRES 21 A 262 GLY PHE SEQRES 1 B 262 GLY ASN SER VAL GLN GLN GLN LEU GLU ALA LEU GLU LYS SEQRES 2 B 262 SER SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASN THR SEQRES 3 B 262 ALA ASP ASN SER GLN ILE LEU TYR ARG ALA ASP GLU ARG SEQRES 4 B 262 PHE ALA MET CYS SER THR SER LYS VAL MET ALA ALA ALA SEQRES 5 B 262 ALA VAL LEU LYS GLN SER GLU SER ASP LYS HIS LEU LEU SEQRES 6 B 262 ASN GLN ARG VAL GLU ILE LYS LYS SER ASP LEU VAL ASN SEQRES 7 B 262 TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR MET SEQRES 8 B 262 THR LEU ALA GLU LEU GLY ALA ALA ALA LEU GLN TYR SER SEQRES 9 B 262 ASP ASN THR ALA MET ASN LYS LEU ILE ALA HIS LEU GLY SEQRES 10 B 262 GLY PRO ASP LYS VAL THR ALA PHE ALA ARG SER LEU GLY SEQRES 11 B 262 ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR LEU SEQRES 12 B 262 ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR THR SEQRES 13 B 262 PRO LEU ALA MET ALA GLN THR LEU LYS ASN LEU THR LEU SEQRES 14 B 262 GLY LYS ALA LEU ALA GLU THR GLN ARG ALA GLN LEU VAL SEQRES 15 B 262 THR TRP LEU LYS GLY ASN THR THR GLY SER ALA SER ILE SEQRES 16 B 262 ARG ALA GLY LEU PRO LYS SER TRP VAL VAL GLY ASP LYS SEQRES 17 B 262 THR GLY SER GLY ASP TYR GLY THR THR ASN ASP ILE ALA SEQRES 18 B 262 VAL ILE TRP PRO GLU ASN HIS ALA PRO LEU VAL LEU VAL SEQRES 19 B 262 THR TYR PHE THR GLN PRO GLU GLN LYS ALA GLU ARG ARG SEQRES 20 B 262 ARG ASP ILE LEU ALA ALA ALA ALA LYS ILE VAL THR HIS SEQRES 21 B 262 GLY PHE HET OP0 A 301 20 HET EDO A 302 4 HET OP0 B 301 20 HET EDO B 302 4 HETNAM OP0 (2S,5R)-N-(2-AMINOETHOXY)-1-FORMYL-5-[(SULFOOXY) HETNAM 2 OP0 AMINO]PIPERIDINE-2-CARBOXAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 OP0 2(C9 H18 N4 O7 S) FORMUL 4 EDO 2(C2 H6 O2) FORMUL 7 HOH *368(H2 O) HELIX 1 AA1 ASN A 27 GLY A 41 1 15 HELIX 2 AA2 CYS A 69 THR A 71 5 3 HELIX 3 AA3 SER A 72 GLU A 85 1 14 HELIX 4 AA4 HIS A 89 ASN A 92 5 4 HELIX 5 AA5 LYS A 98 LEU A 102 5 5 HELIX 6 AA6 ILE A 108 HIS A 112 5 5 HELIX 7 AA7 LEU A 119 TYR A 129 1 11 HELIX 8 AA8 ASP A 131 GLY A 143 1 13 HELIX 9 AA9 GLY A 144 LEU A 155 1 12 HELIX 10 AB1 PRO A 167 THR A 171 5 5 HELIX 11 AB2 THR A 182 LEU A 195 1 14 HELIX 12 AB3 ALA A 200 GLY A 213 1 14 HELIX 13 AB4 SER A 220 LEU A 225 5 6 HELIX 14 AB5 ARG A 275 THR A 287 1 13 HELIX 15 AB6 SER B 28 SER B 40 1 13 HELIX 16 AB7 CYS B 69 THR B 71 5 3 HELIX 17 AB8 SER B 72 GLU B 85 1 14 HELIX 18 AB9 HIS B 89 ASN B 92 5 4 HELIX 19 AC1 LYS B 98 LEU B 102 5 5 HELIX 20 AC2 ILE B 108 VAL B 113 5 6 HELIX 21 AC3 LEU B 119 TYR B 129 1 11 HELIX 22 AC4 ASP B 131 GLY B 143 1 13 HELIX 23 AC5 GLY B 144 LEU B 155 1 12 HELIX 24 AC6 PRO B 167 THR B 171 5 5 HELIX 25 AC7 THR B 182 LEU B 195 1 14 HELIX 26 AC8 ALA B 200 GLY B 213 1 14 HELIX 27 AC9 SER B 220 LEU B 225 5 6 HELIX 28 AD1 ARG B 275 HIS B 288 1 14 SHEET 1 AA1 5 GLN A 56 TYR A 60 0 SHEET 2 AA1 5 ARG A 43 ASN A 50 -1 N VAL A 46 O TYR A 60 SHEET 3 AA1 5 LEU A 259 THR A 266 -1 O TYR A 264 N GLY A 45 SHEET 4 AA1 5 THR A 243 TRP A 251 -1 N THR A 244 O PHE A 265 SHEET 5 AA1 5 VAL A 230 GLY A 238 -1 N VAL A 230 O TRP A 251 SHEET 1 AA2 2 PHE A 66 ALA A 67 0 SHEET 2 AA2 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66 SHEET 1 AA3 2 ARG A 94 ILE A 97 0 SHEET 2 AA3 2 GLY A 115 THR A 118 -1 O GLY A 115 N ILE A 97 SHEET 1 AA4 5 GLN B 56 TYR B 60 0 SHEET 2 AA4 5 ARG B 43 ASN B 50 -1 N VAL B 46 O TYR B 60 SHEET 3 AA4 5 LEU B 259 THR B 266 -1 O TYR B 264 N GLY B 45 SHEET 4 AA4 5 THR B 243 TRP B 251 -1 N ALA B 248 O LEU B 261 SHEET 5 AA4 5 VAL B 230 GLY B 238 -1 N VAL B 230 O TRP B 251 SHEET 1 AA5 2 PHE B 66 ALA B 67 0 SHEET 2 AA5 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66 SHEET 1 AA6 2 ARG B 94 GLU B 96 0 SHEET 2 AA6 2 THR B 116 THR B 118 -1 O MET B 117 N VAL B 95 LINK OG SER A 70 C1 OP0 A 301 1555 1555 1.36 LINK OG SER B 70 C1 OP0 B 301 1555 1555 1.36 CISPEP 1 GLU A 166 PRO A 167 0 6.15 CISPEP 2 GLU B 166 PRO B 167 0 3.50 SITE 1 AC1 14 CYS A 69 SER A 70 ASN A 104 SER A 130 SITE 2 AC1 14 ASN A 132 ASN A 170 THR A 216 LYS A 234 SITE 3 AC1 14 THR A 235 GLY A 236 SER A 237 ASP A 240 SITE 4 AC1 14 HOH A 404 HOH A 520 SITE 1 AC2 6 ALA A 172 ILE A 173 GLY A 175 ASP A 176 SITE 2 AC2 6 HOH A 417 HOH A 438 SITE 1 AC3 8 ARG B 65 ALA B 67 ALA B 172 ILE B 173 SITE 2 AC3 8 GLY B 175 ASP B 176 HOH B 401 HOH B 418 SITE 1 AC4 17 MET B 68 CYS B 69 THR B 71 SER B 72 SITE 2 AC4 17 LYS B 73 ASN B 104 SER B 130 ASN B 132 SITE 3 AC4 17 ASN B 170 THR B 216 LYS B 234 THR B 235 SITE 4 AC4 17 GLY B 236 SER B 237 ASP B 240 HOH B 411 SITE 5 AC4 17 HOH B 484 CRYST1 51.533 72.982 63.052 90.00 109.29 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019405 0.000000 0.006793 0.00000 SCALE2 0.000000 0.013702 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016804 0.00000